New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity

DecisionDx-Melanoma continues to demonstrate strong performance in helping physicians make more informed, risk-aligned ...
ascopubs.org

Could Adjuvant Radiotherapy Be Avoided for Postmenopausal Patients With Node-Positive Estrogen Receptor–Positive Breast Cancer and Favorable Recurrence Score and SET2,3 Scores?

Could Adjuvant Radiotherapy Be Avoided for Postmenopausal Patients With Node-Positive Estrogen Receptor–Positive Breast Cancer and Favorable Recurrence Score and SET2,3 Scores? The following ...